Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Lumacaftor + Ivacaftor in CF
NCT01931839Phase 3Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Oct 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of lumacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started Oct 2013; status: completed.
02
Drugs
lumacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01931839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01931839.